The global pediatric clinical trial market with a predicted compound annual growth rate (CAGR) of 5.9% from 2024 to 2034, the company is expected to experience tremendous expansion. Based on this projected trend, the market value is anticipated to soar from US$ 17,918.1 million in 2024 to an astounding US$ 31,661.0 million by 2034. Notably, …